Clinical management of BRCA1 and BRCA2 mutation carriers.
about
Breast cancer in the personal genomics eraAdjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerVariants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancerEmotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic reviewATM and breast cancer susceptibility.What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.Management options after prophylactic surgeries in women with BRCA mutations: a review.Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?Update on genetic predisposition to breast cancer.Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.Assessing women at high risk of breast cancer: a review of risk assessment models.Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.Pancreatic cancer: current understanding of molecular and genetic aetiologies.Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.Active approach for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact.Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels.Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in mice.BRCA in breast cancer: ESMO Clinical Practice Guidelines
P2860
Q24602679-E30485DC-359A-4AA1-B58E-C7F4BA44DB3DQ30430808-C816A3A8-AE1F-4F1F-B82C-5A570FEF1F56Q30487580-0908ED31-8218-46DF-A813-6429129D28ADQ33482054-7554A346-0F0E-41EF-AFFD-3F02E69DFDFAQ33594181-54B18800-B81F-495B-B6F9-283869179538Q34568565-A85ACFB4-35FD-4393-81FC-5FCC85CE4D86Q35370858-5419B25D-58F3-4C08-B084-4F70FAE56666Q35930061-F0683A4E-4330-4137-B87E-46ED65ACFF4BQ36840576-E8FF37A7-1D66-4E23-BCFE-17769F9E393DQ36955087-33A45D1C-3279-45F3-9C3B-A6A368FD183DQ36959824-A6B52289-3FD6-4019-BF27-32ADE5521461Q37131303-959F823E-C197-46BC-A227-F2FF1B3FBF2CQ37310845-05F4E25D-9867-40E5-B498-E62EDABB2419Q37577923-4DA2A16D-DCE7-4BA3-B521-E918F9EE83D8Q37619695-3335CF65-769C-4AC4-80F1-45BE3BBCFB41Q37739036-96788B4F-C597-4966-ABDB-E217F84ACEF1Q38175815-181DB5D2-0AB6-47F6-A5EA-46AFB857AD6AQ38540431-C23A40F4-B02E-4E1D-A06D-9E7270ABE86FQ39637429-8F4E75E2-451E-4341-A971-362BF541BCE5Q46354502-42F9A2EB-5679-40D1-B5BD-FEE65F6D3D4AQ47973656-DD537FCB-6E99-43E3-86D2-216C15CF894AQ48379198-B5BC2969-F9CC-430D-8E35-B3931EE6E310Q50300704-489E83A8-7A05-4574-A122-637BF07C8C26Q51272824-68710820-B654-4E75-BE05-D7F9B90BB85EQ59274104-A2FC7DEC-F817-487A-AF7A-D42AB422316C
P2860
Clinical management of BRCA1 and BRCA2 mutation carriers.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical management of BRCA1 and BRCA2 mutation carriers.
@ast
Clinical management of BRCA1 and BRCA2 mutation carriers.
@en
Clinical management of BRCA1 and BRCA2 mutation carriers.
@nl
type
label
Clinical management of BRCA1 and BRCA2 mutation carriers.
@ast
Clinical management of BRCA1 and BRCA2 mutation carriers.
@en
Clinical management of BRCA1 and BRCA2 mutation carriers.
@nl
prefLabel
Clinical management of BRCA1 and BRCA2 mutation carriers.
@ast
Clinical management of BRCA1 and BRCA2 mutation carriers.
@en
Clinical management of BRCA1 and BRCA2 mutation carriers.
@nl
P2860
P356
P1433
P1476
Clinical management of BRCA1 and BRCA2 mutation carriers.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209881
P407
P577
2006-09-01T00:00:00Z
P5875
P6179
1034520179